Boston Scientific appoints Joseph M. Fitzgerald Executive Vice President and Chief Operating Officer
New operating structure designed to increase efficiency and support continued growth MARLBOROUGH, Mass., Oct. 7, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the appointment of Joseph M. Fitzgerald to executive vice president and chief operating officer...
Covered in this story
What has happened since
- Boston Scientific is up 9.6% since this was published, 13 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Boston Scientific
- Bernstein: $42.4 → $54 by Oct 2027 · Outperform via Investing.com
- TD Cowen: $47.8 → $56 by Sep 2027 · Buy via Investing.com
- Stifel: $48.2 → $60 by Aug 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $BSX yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Boston Scientific →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.